Literature DB >> 24229029

Tumor compression-induced portal obstruction and selective transarterial chemoembolization increase functional liver volume in the unobstructed area, facilitating successful resection of a large HCC.

Ryuma Tokunaga1, Hiromitsu Hayashi, Toshiro Masuda, Kosuke Mima, Akira Chikamoto, Hiroshi Tanaka, Kei Horino, Takatoshi Ishiko, Hiroshi Takamori, Toru Beppu, Hideo Baba.   

Abstract

A 62-year-old man with hepatitis B was admitted for treatment of a large hepatocellular carcinoma. The right portal vein was completely obstructed by tumor compression. Although we initially planned a right trisectionectomy as curative hepatectomy, the percentage of future remnant liver volume (%RLV) and the percentage of functional liver volume (%RFLV) were 31.2% and 41.3%, respectively. Because %RFLV showed marginal tolerability for curative hepatectomy and %RLV was very low, we opted for transarterial chemoembolization of segment IV and the right lobe containing the tumor as an approach to selectively reduce liver volume and abolish liver function. One month later, %RLV and %RFLV had dramatically increased to 46.6% and 67.2%, resulting in curative hepatectomy. Our results suggest that tumor compression-induced portal obstruction and selective transarterial chemoembolization increase %RFLV much more than %RLV. This may represent a useful approach in preoperative management in patients with large hepatocellular carcinomas to improve %RFLV for hepatic resection.

Entities:  

Mesh:

Year:  2013        PMID: 24229029      PMCID: PMC3829069          DOI: 10.9738/INTSURG-D-13-00013.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  9 in total

Review 1.  Portal vein embolization: rationale, technique and future prospects.

Authors:  E K Abdalla; M E Hicks; J N Vauthey
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

Review 2.  Current role of portal vein embolization/hepatic artery chemoembolization.

Authors:  Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Surg Clin North Am       Date:  2004-04       Impact factor: 2.741

Review 3.  Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review.

Authors:  Y Yokoyama; M Nagino; Y Nimura
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

4.  Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.

Authors:  Jun Luo; Zhen-Wei Peng; Rong-Ping Guo; Ya-Qi Zhang; Jin-Qing Li; Min-Shan Chen; Ming Shi
Journal:  Radiology       Date:  2011-02-17       Impact factor: 11.105

5.  Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

Authors:  Chin-Ta Lin; Kuo-Feng Hsu; Teng-Wei Chen; Jyh-Cherng Yu; De-Chuan Chan; Chih-Yung Yu; Tsai-Yuan Hsieh; Hsiu-Lung Fan; Shih-Ming Kuo; Kuo-Piao Chung; Chung-Bao Hsieh
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

6.  Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma.

Authors:  Hyunkyung Yoo; Jin Hyoung Kim; Gi-Young Ko; Kyoung Won Kim; Dong Il Gwon; Sung-Gyu Lee; Shin Hwang
Journal:  Ann Surg Oncol       Date:  2010-11-11       Impact factor: 5.344

7.  Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus.

Authors:  Zhen-Wei Peng; Rong-Ping Guo; Yao-Jun Zhang; Xiao-Jun Lin; Min-Shan Chen; Wan Y Lau
Journal:  Cancer       Date:  2012-02-22       Impact factor: 6.860

8.  Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system.

Authors:  Toru Beppu; Hiromitsu Hayashi; Hirohisa Okabe; Toshiro Masuda; Kosuke Mima; Ryu Otao; Akira Chikamoto; Koichi Doi; Takatoshi Ishiko; Hiroshi Takamori; Morikatsu Yoshida; Shinya Shiraishi; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2011-04-27       Impact factor: 7.527

9.  Transcatheter arterial chemoembolization for hepatocellular carcinoma after attempted portal vein embolization in 25 patients.

Authors:  Bo-Kyeong Kang; Jin Hyoung Kim; Kwang Mi Kim; Gi-Young Ko; Hyun-Ki Yoon; Dong Il Gwon; Kyu-Bo Sung
Journal:  AJR Am J Roentgenol       Date:  2009-11       Impact factor: 3.959

  9 in total
  1 in total

Review 1.  Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma.

Authors:  Toru Beppu; Kensuke Yamamura; Hirohisa Okabe; Katsunori Imai; Hiromitsu Hayashi
Journal:  Ann Gastroenterol Surg       Date:  2020-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.